| 1 | [SID14729216] | Active | CC50 | 1.12e-06 | Cytotoxicity counterscreen assay for transcriptional activators of heat shock protein 70 (Hsp70) [AID1259, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | CC50 | 1.12e-06 [uM] | | BioAssay | Cytotoxicity counterscreen assay for transcriptional activators of heat shock protein 70 (Hsp70) | | AID | 1259 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID14729216] | Active | IC50 | 0.16 | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489033, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.16 [uM] | | BioAssay | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489033 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID14729216] | Active | IC50 | 0.2 | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol [AID449764, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol | | AID | 449764 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID14729216] | Active | IC50 | 0.2 | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID14729216] | Active | IC50 | 0.32 | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay [AID489035, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.32 [uM] | | BioAssay | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay | | AID | 489035 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID14729216] | Active | IC50 | 0.396 | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1692, Type: confirmatory] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.396 [uM] | | BioAssay | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1692 | | BioAssay type | confirmatory | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 7 | [SID14729216] | Active | IC50 | 0.396 | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1692, Type: confirmatory] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.396 [uM] | | BioAssay | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1692 | | BioAssay type | confirmatory | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 8 | [SID14729216] | Active | IC50 | 0.752 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.752 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 9 | [SID14729216] | Active | IC50 | 0.752 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.752 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 10 | [SID14729216] | Active | IC50 | 0.752 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.752 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 11 | [SID14729216] | Active | EC50 | 0.84 | E3 Ligase_Mutant_Dose Response [AID1442, Type: confirmatory] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | EC50 | 0.84 [uM] | | BioAssay | E3 Ligase_Mutant_Dose Response | | AID | 1442 | | BioAssay type | confirmatory | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 12 | [SID14729216] | Active | EC50 | 0.84 | E3 Ligase_Mutant_Dose Response [AID1442, Type: confirmatory] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | EC50 | 0.84 [uM] | | BioAssay | E3 Ligase_Mutant_Dose Response | | AID | 1442 | | BioAssay type | confirmatory | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 13 | [SID14729216] | Active | AC50 | 0.8547 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | AC50 | 0.8547 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID14729216] | Active | IC50 | 0.87907 | Luminescence-based dose response cell-based high throughput screening assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line. [AID1972, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.87907 [uM] | | BioAssay | Luminescence-based dose response cell-based high throughput screening assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line. | | AID | 1972 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID14729216] | Active | EC50 | 0.96 | E3 Ligase dose-response_384 [AID1394, Type: confirmatory] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | EC50 | 0.96 [uM] | | BioAssay | E3 Ligase dose-response_384 | | AID | 1394 | | BioAssay type | confirmatory | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 16 | [SID14729216] | Active | EC50 | 0.96 | E3 Ligase dose-response_384 [AID1394, Type: confirmatory] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | EC50 | 0.96 [uM] | | BioAssay | E3 Ligase dose-response_384 | | AID | 1394 | | BioAssay type | confirmatory | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 17 | [SID14729216] | Active | IC50 | 0.967 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.967 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 18 | [SID14729216] | Active | IC50 | 0.967 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.967 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 19 | [SID14729216] | Active | IC50 | 0.967 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 0.967 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 20 | [SID14729216] | Active | Potency | 1 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 21 | [SID14729216] | Active | Potency | 1 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 22 | [SID14729216] | Active | AC50 | 1.3 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | AC50 | 1.3 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID14729216] | Active | EC50 | 1.73 | E3 Ligase_WT_Dose Response [AID1444, Type: confirmatory] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | EC50 | 1.73 [uM] | | BioAssay | E3 Ligase_WT_Dose Response | | AID | 1444 | | BioAssay type | confirmatory | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 24 | [SID14729216] | Active | EC50 | 1.73 | E3 Ligase_WT_Dose Response [AID1444, Type: confirmatory] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | EC50 | 1.73 [uM] | | BioAssay | E3 Ligase_WT_Dose Response | | AID | 1444 | | BioAssay type | confirmatory | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 25 | [SID14729216] | Active | CC50 | 2.129 | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis [AID435019, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | CC50 | 2.129 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis | | AID | 435019 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID14729216] | Active | Potency | 2.2387 | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1491, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1491 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 27 | [SID14729216] | Active | Potency | 2.2387 | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1491, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1491 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 28 | [SID14729216] | Active | Potency | 2.2387 | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Calcium Signal Transduction [AID1489, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Calcium Signal Transduction | | AID | 1489 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 29 | [SID14729216] | Active | Potency | 2.2387 | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Calcium Signal Transduction [AID1489, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Calcium Signal Transduction | | AID | 1489 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 30 | [SID14729216] | Active | IC50 | 2.255 | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor [AID463214, Type: confirmatory] | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 2.255 [uM] | | BioAssay | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor | | AID | 463214 | | BioAssay type | confirmatory | | Target | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] | | PubMed | | | Data Table |  |
|
| 31 | [SID14729216] | Active | IC50 | 2.255 | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor [AID463214, Type: confirmatory] | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 2.255 [uM] | | BioAssay | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor | | AID | 463214 | | BioAssay type | confirmatory | | Target | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] | | PubMed | | | Data Table |  |
|
| 32 | [SID14729216] | Active | IC50 | 3.76 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 3.76 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 33 | [SID14729216] | Active | IC50 | 3.76 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 3.76 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 34 | [SID14729216] | Active | IC50 | 3.76 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 3.76 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 35 | [SID14729216] | Active | IC50 | 3.76 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 3.76 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 36 | [SID14729216] | Active | IC50 | 4.24 | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2784, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.24 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2784 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 37 | [SID14729216] | Active | IC50 | 4.24 | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2784, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.24 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2784 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 38 | [SID14729216] | Active | IC50 | 4.455 | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) [AID1821, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.455 [uM] | | BioAssay | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) | | AID | 1821 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 39 | [SID14729216] | Active | IC50 | 4.455 | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) [AID1821, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.455 [uM] | | BioAssay | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) | | AID | 1821 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 40 | [SID14729216] | Active | IC50 | 4.706 | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor [AID2136, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.706 [uM] | | BioAssay | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor | | AID | 2136 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 41 | [SID14729216] | Active | IC50 | 4.706 | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor [AID2136, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.706 [uM] | | BioAssay | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor | | AID | 2136 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 42 | [SID14729216] | Active | IC50 | 4.706 | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor [AID2136, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.706 [uM] | | BioAssay | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor | | AID | 2136 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 43 | [SID14729216] | Active | IC50 | 4.706 | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor [AID2136, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 4.706 [uM] | | BioAssay | HTS Image-Based Screen for Selective Antagonists of the KOR Receptor | | AID | 2136 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 44 | [SID14729216] | Active | Potency | 5.0119 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 45 | [SID14729216] | Active | Potency | 5.0119 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 46 | [SID14729216] | Active | IC50 | 5.5 | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay [AID489041, Type: confirmatory] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | IC50 | 5.5 [uM] | | BioAssay | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay | | AID | 489041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID14729216] | Active | EC50 | 5.743 | Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Platelet Dense Granule Release [AID1889, Type: confirmatory] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | EC50 | 5.743 [uM] | | BioAssay | Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Platelet Dense Granule Release | | AID | 1889 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID14729216] | Active | Potency | 10 | Counterscreen Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Muscarinic Receptor Calcium Signal Transduction. [AID1492, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Counterscreen Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Muscarinic Receptor Calcium Signal Transduction. | | AID | 1492 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 49 | [SID14729216] | Active | Potency | 10 | Counterscreen Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Muscarinic Receptor Calcium Signal Transduction. [AID1492, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Counterscreen Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Muscarinic Receptor Calcium Signal Transduction. | | AID | 1492 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|
| 50 | [SID14729216] | Active | Potency | 10 | Counterscreen Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Muscarinic Receptor Calcium Signal Transduction. [AID1492, Type: confirmatory] | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 14729216 | | CID | 1472225 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Counterscreen Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Muscarinic Receptor Calcium Signal Transduction. | | AID | 1492 | | BioAssay type | confirmatory | | Target | muscarinic acetylcholine receptor M1 [Rattus norvegicus] [gi:18249941] | | PubMed | | | Data Table |  |
|